| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.5 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |